IP Library Granted Patent US 10,676,441
Granted Patent B2
US 10,676,441 · App. 15/749,377 · Granted Jun 9, 2020

Method for producing pitavastatin calcium

Inventors: Naoyuki Watanabe (Fukuoka, JP); Takanobu Iura (Kanagawa, JP); Hideki Oomiya (Fukuoka, JP); Masaki Nagahama (Fukuoka, JP)
Assignee: API CORPORATION
C07D215/14C12P17/12A61K31/47C07B61/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,676,441
App. No.
15/749,377
Granted
Jun 9, 2020
Kind
B2
Abstract

Production of pitavastatin calcium safely on an industrial scale with a high yield and high selectivity at low cost. A method of producing pitavastatin calcium including step (i) for acetalizing a compound represented by the formula (1) to give a compound represented by the formula (3), step (ii) for reacting a compound represented by the formula (3) with an acid to give a compound represented by the formula (4), and step (iii) for hydrolyzing a compound represented by the formula (4) and reacting same with a calcium compound.

Claims (24)

1. A method for producing pitavastatin calcium comprising

(i) acetalizing a compound represented by the following formula (1):

wherein R is a straight chain alkyl group having a carbon number of 1-8 or a branched alkyl group having a carbon number of 3-8 and X is an acid, to give a compound represented by the following formula (3):

wherein R 3 and R 4 are each independently an alkyl group having a carbon number of 1-4 and R is as defined above;

(ii) reacting said compound represented by the formula (3) with an acid to give a compound represented by the following formula (4):

wherein R is as defined above; and

(iii) hydrolyzing said compound represented by the formula (4) and reacting the compound with a calcium compound to give pitavastatin calcium.

2. The production method according to claim 1 , wherein the compound represented by the formula (1) used in (i) is obtained by

(iv) reacting a compound represented by the following formula (6):

wherein R is a straight chain alkyl group having a carbon number of 1-8 or a branched alkyl group having a carbon number of 3-8, with an acid.

3. The production method according to claim 2 , wherein the compound represented by the formula (6) used in (iv) is obtained by

(v) condensing a compound represented by the following formula (7):

and a compound represented by the following formula (8):

wherein R 5 is a straight chain alkyl group having a carbon number of 1-8 or a branched alkyl group having a carbon number of 3-8 provided R 5 is different from R in said formula (1), in the presence of a base to give a compound represented by the following formula (9):

wherein R 5 is as defined above;

(vi) reacting said compound represented by the formula (9) obtained in (v) with alcohol represented by R—OH wherein R is a straight chain alkyl group having a carbon number of 1-8 or a branched alkyl group having a carbon number of 3-8 to give a compound represented by the following formula (10):

wherein R is as defined above; and

(vii) reacting said compound represented by the formula (10) obtained in (vi) with an enzyme having an activity capable of stereoselectively reducing a carbonyl group, a microorganism or cell having an ability to produce the enzyme, a treated product of the microorganism or cell, and/or a culture solution containing the enzyme obtained by culturing the microorganism or cell.

4. The production method according to claim 2 , wherein the compound represented by the formula (6) used in (iv) is obtained by

(viii) reacting a compound represented by the following formula (12):

in the presence of a titanium catalyst with a compound represented by the following formula (13):

wherein R is a straight chain alkyl group having a carbon number of 1-8 or a branched alkyl group having a carbon number of 3-8, to give a compound represented by the following formula (14):

wherein R is as defined above; and

(ix) reacting said compound represented by the formula (14) obtained in (viii) with an enzyme having an activity capable of stereoselectively reducing a carbonyl group, a microorganism or cell having an ability to produce the enzyme, a treated product of the microorganism or cell, and/or a culture solution containing the enzyme obtained by culturing the microorganism or cell.

Assignments (3)
CHANGE OF ADDRESS Recorded Aug 21, 2025
From: API CORPORATION
To: API CORPORATION
Reel/Frame 072498/0511 →
MERGER Recorded Aug 21, 2025
From: API CORPORATION
To: UBE CORPORATION
Reel/Frame 072554/0211 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 26, 2018
From: WATANABE, NAOYUKI; IURA, TAKANOBU; OOMIYA, HIDEKI; NAGAHAMA, MASAKI
To: API CORPORATION
Reel/Frame 045348/0110 →
Priority Claims (1)
JP 2015-154864 · Aug 5, 2015 · national
Continuity (1)
Related Publication 20180222865A1 · Aug 9, 2018